Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...

The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi ... priced at a similar level to the glucagon injection kits available on the market, with a ...

Teladoc said in a news release the partnership with Eli Lilly will help increase access for members in its weight management program who do not have insurance coverage for glucagon-like peptide-1 ...

Danish biopharma powerhouse Novo Nordisk is taking another bold move in the obesity market, this time licensing a new type of GLP-1 that could directly compete with a candidate in Eli Lilly’s ...